Validating effectiveness of subgroup identification for longitudinal data
From MaRDI portal
Cites work
- Analysis of randomized comparative clinical trial data for personalized treatment selections
- Effectively Selecting a Target Population for a Future Comparative Study
- Evaluating Markers for Selecting a Patient's Treatment
- Improving generalised estimating equations using quadratic inference functions
- Individualizing drug dosage with longitudinal data
- Inference for subgroup analysis with a structured logistic-normal mixture model
- Longitudinal data analysis using generalized linear models
- Mastering variation: variance components and personalised medicine
- Maximum Likelihood Approaches to Variance Component Estimation and to Related Problems
- Maximum-likelihood estimation for the mixed analysis of variance model
- Measuring the individual benefit of a medical or behavioral treatment using generalized linear mixed-effects models
- Patterns of treatment effects in subsets of patients in clinical trials
- Personalize treatment for longitudinal data using unspecified random-effects model
- Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes
- Subgroup analysis with time-to-event data under a logistic-Cox mixture model
This page was built for publication: Validating effectiveness of subgroup identification for longitudinal data
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q7022154)